Reuters logo
BRIEF-Alembic Pharmaceuticals says no 483s issued by FDA for Baroda bioequivalence facility inspection
April 17, 2017 / 7:01 AM / 8 months ago

BRIEF-Alembic Pharmaceuticals says no 483s issued by FDA for Baroda bioequivalence facility inspection

April 17 (Reuters) - Alembic Pharmaceuticals Ltd

* Says company’s bioequivalence facility located at baroda was inspected by US Food & Drug Administration

* Says were no 483s issued by US FDA at end of inspection Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below